Download
12920_2024_Article_2053.pdf 1,05MB
WeightNameValue
1000 Titel
  • Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencing
1000 Autor/in
  1. Wieting, Jelte |
  2. Jahn, Kirsten |
  3. Bleich, Stefan |
  4. Deest, Maximilian |
  5. Frieling, Helge |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-11-29
1000 Erschienen in
1000 Quellenangabe
  • 17(1):279
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12920-024-02053-9 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11606058/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>MAGEL2 is an autism susceptibility gene whose deficiency has been associated with autism-related behaviors in animal models and in syndromic human autism spectrum disorders (ASDs) such as Schaaf-Yang syndrome, but has not been studied in the broader autism spectrum. Given the capabilities of long-read sequencing technologies, this pilot study used a targeted nanopore sequencing approach to simultaneously examine MAGEL2 DNA sequence and methylation in adults with high-functioning autism (HFA) compared to neurotypical controls (NC).</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Using DNA extracted from peripheral blood, Cas9-targeted nanopore DNA sequencing was used to analyze MAGEL2, including its entire regulatory construct (chr15:23639316–23651466), for sequence variation and 5-methyl-cytosine (5mC) modification in a cohort of adults with HFA compared to sex- and age-matched NC. Given the known sex differences in ASD and MAGEL2 KO animal models, results were further analyzed by sex.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>20 adults with HFA (10 males, 10 females) and 20 NC were included. While there were no overall differences in MAGEL2 DNA sequence and 5mC modification between HFA and NC, we found a significant difference in MAGEL2 gene promoter methylation between males and females with HFA and NC of both sexes, with HFA males tending to show hypomethylation in a 300 bp long differentially methylated region (chr15:23647640–23647939) around the MAGEL2 transcription start site.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>In this pilot study utilizing nanopore Cas9 targeted DNA sequencing, significant sex-specific differences in MAGEL2 gene promoter methylation were identified in male adults with HFA in comparison to control groups, suggesting the potential for sex-specific epigenetic differences. However, further replication in larger cohorts is required to validate these findings.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Female [MeSH]
lokal Genomics of neurodevelopmental disorders
lokal 5mC modification
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Adult
lokal Autism spectrum disorder
lokal Middle Aged [MeSH]
lokal MAGEL2
lokal Methylation
lokal Nanopore Cas9 targeted sequencing
lokal Sex differences
lokal NCATS
lokal Nanopore Sequencing [MeSH]
lokal Autistic Disorder/genetics [MeSH]
lokal Male [MeSH]
lokal DNA Methylation [MeSH]
lokal Long read sequencing
lokal Research
lokal Pilot Projects [MeSH]
lokal Sex Characteristics [MeSH]
lokal Sex Factors [MeSH]
lokal High-functioning autism
lokal Promoter Regions, Genetic [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/V2lldGluZywgSmVsdGU=|https://frl.publisso.de/adhoc/uri/SmFobiwgS2lyc3Rlbg==|https://frl.publisso.de/adhoc/uri/QmxlaWNoLCBTdGVmYW4=|https://frl.publisso.de/adhoc/uri/RGVlc3QsIE1heGltaWxpYW4=|https://frl.publisso.de/adhoc/uri/RnJpZWxpbmcsIEhlbGdl
1000 Hinweis
  • DeepGreen-ID: 50dce6243ad9449c9467f9f7c8705ccf ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. PRACTIS - Clinician Scientist Program of Hannover Medical School, funded by the German Research Foundation |
  2. Medizinische Hochschule Hannover (MHH) |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer PRACTIS - Clinician Scientist Program of Hannover Medical School, funded by the German Research Foundation |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Medizinische Hochschule Hannover (MHH) |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6522128.rdf
1000 Erstellt am 2025-07-06T12:41:51.180+0200
1000 Erstellt von 322
1000 beschreibt frl:6522128
1000 Zuletzt bearbeitet 2025-07-31T15:57:15.271+0200
1000 Objekt bearb. Thu Jul 31 15:57:15 CEST 2025
1000 Vgl. frl:6522128
1000 Oai Id
  1. oai:frl.publisso.de:frl:6522128 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source